ERBB2 and breast cancer: Patients without neurological symptoms at BM diagnosis showed a better OS in all breast cancer subtypes: For HER-2 positive, the difference was statistically significant, while for triple-negative and luminal A- and B-like patients, statistical significance was not reached.